Trial Profile
Clinical Trial for the Safety, Tolerability, and Pharmacokinetics of TEW-7197 Under Fed or Fasting in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2020
Price :
$35
*
At a glance
- Drugs Vactosertib (Primary)
- Indications Colorectal cancer; Fibroma; Gastric cancer; Multiple myeloma; Myelodysplastic syndromes; Non-small cell lung cancer; Pancreatic cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors MedPacto
- 10 Apr 2020 Status changed from active, no longer recruiting to completed.
- 28 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 23 Oct 2018 New trial record